Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial.

Autor: Scheiman JM; Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109, USA. Electronic address: jscheima@med.umich.edu., Lanas A; Servicio de Aparato Digestivo, University Clinic Hospital, University of Zaragoza, CIBERehd, IIS Aragón, Calle de San Juan Bosco 15, 5009 Zaragoza, Spain. Electronic address: angel.lanas@gmail.com., Veldhuyzen van Zanten S; Division of Gastroenterology, Department of Medicine, 130 University Campus, University of Alberta, Edmonton, Alberta T6G 2X8, Canada. Electronic address: vanzanten@ualberta.ca., Baldycheva I; AstraZeneca LP, 1800 Concord Pike, P.O. Box 15437, Wilmington, DE 19850-5437, USA. Electronic address: irina.baldycheva@astrazeneca.com., Svedberg LE; AstraZeneca R&D, Pepparedsleden 1, Mölndal SE-431 83, Sweden. Electronic address: laersve@gmail.com., Nagy P; AstraZeneca R&D, Pepparedsleden 1, Mölndal SE-431 83, Sweden. Electronic address: peter.nagy@astrazeneca.com.
Jazyk: angličtina
Zdroj: International journal of cardiology [Int J Cardiol] 2015 Mar 01; Vol. 182, pp. 500-2. Date of Electronic Publication: 2014 Dec 30.
DOI: 10.1016/j.ijcard.2014.12.140
Databáze: MEDLINE